B

Blueprint Medicines Corp

D

BPMC

USD

1.63

(1.8251%)

Market Closed

27,961.00

Volume

-4.55

EPS

-

Div Yield

-26.668622

P/E

5,760,636,587.10

Market Cap

Today

1.8251%

1 Week

8.120%

1 Month

-5.004%

6 Months

3.411%

12 Months

77.098%

Year To Date

-1.484%

All Time

0%

Related Instruments

Title:
Blueprint Medicines Corp

Sector:

Healthcare

Industry:

Biotechnology

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

Do you need help or have a question?